DJIA 17,791.89 13.74 0.08%
NASDAQ 4,761.96 13.56 0.29%
S&P 500 2,066.98 5.75 0.28%
market minute promo

Amicus Therapeutics, Inc. (NASDAQ: FOLD)

7.92 0.04 (0.51%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

FOLD $7.92 0.51%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.93
Previous Close $7.88
Daily Range $7.73 - $7.98
52-Week Range $1.77 - $8.79
Market Cap $628.2M
P/E Ratio -8.95
Dividend (Yield) $0.00 (0.0%)
Volume 260,441
Average Daily Volume 2,061,883
Current FY EPS -$0.87





Amicus Therapeutics, Inc. (FOLD) Description

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases. Website:

News & Commentary Rss Feed

This Tiny Biotech Worries Sanofi and Shire, and Vexes GlaxoSmithKline

Amicus Therapeutics plans to file for EU approval of a treatment for Fabry Disease that could challenge Sanofi and Shire.

NPS Pharmaceuticals Spikes 19% Amid Shire Bid Report

These 4 Biotech Stocks Have Been On Fire

3 Large Cap Biotech Stocks That Could Pay Dividends, But Won't

Gilead Sciences, Celgene, and Biogen all have rock-solid financials, but none are likely to pay a dividend anytime soon.

Will Amicus Therapeutics (FOLD) Continue to Surge Higher? - Tale of the Tape

Amicus Therapeutics (FOLD) Weak On High Volume

Warren Buffett Pick CBI Tumbles On Rating Downgrade

Health Care Sector Update for 11/19/2014: MNK, FOLD

Benzinga's Top #PreMarket Losers

Amicus Therapeutics, Inc. (FOLD) in Focus: Stock Soars 17.8% - Tale of the Tape

See More FOLD News...

FOLD's Top Competitors

FOLD $7.92 (0.51%)
Current stock: FOLD
AMGN $169.19 (0.42%)
Current stock: AMGN
GILD $108.02 (2.35%)
Current stock: GILD
BIIB $357.39 (1.04%)
Current stock: BIIB